Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
CG sets new bar in bladder cancer, months after huge IPO
CG plans to file a new drug application for its bladder cancer treatment in 2025.
Max Bayer
May 3, 2024 11:23am
‘Next wave of IPOs’ will arrive in summer, predicts VC partner
May 3, 2024 10:49am
Contineum lowers expectations for $110M IPO
Apr 5, 2024 7:00am
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Apr 3, 2024 9:00am
Boundless boldly goes public with $100M IPO
Mar 28, 2024 7:10am
Boundless Bio eyes $88M offering as spring IPO market blooms
Mar 21, 2024 8:50am